Related Experiment Video
Updated: Feb 20, 2026
09:36
Assessment of Child Anthropometry in a Large Epidemiologic Study
Published on: February 2, 2017
27.9K
Obesity in children and adolescents
Casey Berman1, Brenda Kohn1, Don Wilson2
1NYU Langone Health, New York, NY, USA (Drs Berman and Kohn).
Journal of Clinical Lipidology
|February 18, 2026
Summary
Childhood obesity is a growing epidemic impacting children and adolescents. Management requires a unique approach focusing on prevention and high-risk individuals, utilizing Intensive Health Behavioral and Lifestyle Treatment (IHBLT), surgery, or pharmacologic therapies.
Area of Science:
- Pediatrics
- Public Health
- Endocrinology
Background:
- The United States faces a significant obesity epidemic affecting both adults and the pediatric population.
- Pediatric obesity is a chronic condition with increasing prevalence.
Purpose of the Study:
- To review current definitions and recommendations for pediatric obesity.
- To discuss the unique aspects, risk factors, and implications of childhood obesity compared to adults.
Main Methods:
- An extensive literature review of 85 articles was conducted.
- The review synthesized information on definitions, prevalence, risk factors, and management strategies.
Main Results:
- Childhood obesity presents unique challenges in progression and management.
- Key management strategies include Intensive Health Behavioral and Lifestyle Treatment (IHBLT), metabolic surgery, and pharmacologic therapies like glucagon-like peptide-1 receptor agonists (GLP-1RAs).
Conclusions:
- Childhood obesity requires a distinct approach focusing on prevention.
- Management should prioritize high-risk individuals and tailored interventions.
Related Concept Videos
01:24Obesity
1.4K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K
01:21Drug Dosing: Obese Patients
279
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
279
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
302
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
302
01:30Bulimia Nervosa
837
Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
837
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
208
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
208
01:27Signs of Puberty
1.6K
Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
1.6K